2021 Community Oncology Conference
J

2021 Data on HCC & mCRC: Atezo+Bev vs. Sorafenib in Unresectable HCC; Pembro vs. Chemo for MMR/MSI-H CRC, Encorafenib+Cetuximab in BRAF V600E Mutations, Trastuzumab+Tucatinib for HER2-Amplified CRC

By 2021 Community Oncology Conference FEATURING Johanna Bendell
By 2021 Community Oncology Conference FEATURING Johanna Bendell
98 views
May 5, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Related Videos

18:21

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

533 views
14:19

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

492 views
20:09

ESMO 2024 Summary: Selecting 1L Therapy and Sequencing After Immunot…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

395 views
04:40

ESMO 2024 Summary: Neoadjuvant Colon Cancer Treatment - Recent Clini…

2024 ESMO Annual Meeting Insights Hub

J. Taieb

330 views
03:08

The Importance of 1L Biomarkers in CRC

Nicholas DeVito

725 views
14:02

ESMO 2024 Summary: Highlights in CRC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

224 views
13:05

ESMO 2024 Summary: Highlights in HCC

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

213 views
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views
11:33

Using ctDNA to Guide Adjuvant Therapy in GI Malignancies

University of Miami Sylvester Comprehensive Cancer Center

P. Hosein

325 views
20:07

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

261 views
24:57

ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckMate 8…

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

561 views
04:39

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - P…

2024 ESMO Annual Meeting Insights Hub

J. Llovet

206 views
11:58

ASCO® 2024 Insights: "5-Year Results From the Randomized DYNAMIC Tri…

2024 ASCO® Annual Meeting Insights Hub

J. Tie

552 views
16:57

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

681 views
17:19

Year in Review: Colorectal Cancer

Moffitt Cancer Center

R. Kim, T. Biachi

2.1K views
05:40

ESMO 2024 Insights: CheckMate 9DW Expanded Analysis - Nivo + Ipi vs.…

2024 ESMO Annual Meeting Insights Hub

H. Karachiwala

135 views
06:46

Anal Cancer Staging and Treatment Options

GRACE

P. Romesser

252 views
14:28

ESMO 2024 Summary: Updates in HCC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

H. Babiker

167 views
09:56

ESMO 2024 Insights: HIMALAYA - 5-Year OS of Tremelimumab + Durvaluma…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

173 views
03:26

Expert Panel on TACE and TARE for HCC: Weighing the Pros and Cons

Integrity CE

M. Pishvaian, R. Salem

91 views
AUTOPLAY